A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic Therapy

Clinical trial NCT06549907 · RECRUITING

Trial details

NCT number: NCT06549907
Sponsor: Peking University Cancer Hospital & Institute
Status: RECRUITING
Study type: OBSERVATIONAL

MSS Metastatic Colorectal Cancers MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy

Start date: 2024-01-10
Primary completion: 2028-09-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.